124 related articles for article (PubMed ID: 35469851)
61. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
[TBL] [Abstract][Full Text] [Related]
62. Overexpression of RIP140 suppresses the malignant potential of hepatocellular carcinoma by inhibiting NF‑κB‑mediated alternative polarization of macrophages.
Hu YC; Yi ZJ; Zhou Y; Li PZ; Liu ZJ; Duan SG; Gong JP
Oncol Rep; 2017 May; 37(5):2971-2979. PubMed ID: 28393222
[TBL] [Abstract][Full Text] [Related]
63. Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro.
Chen WT; Hsu FT; Liu YC; Chen CH; Hsu LC; Lin SS
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30754643
[TBL] [Abstract][Full Text] [Related]
64. Aurora-a confers radioresistance in human hepatocellular carcinoma by activating NF-κB signaling pathway.
Shen ZT; Chen Y; Huang GC; Zhu XX; Wang R; Chen LB
BMC Cancer; 2019 Nov; 19(1):1075. PubMed ID: 31703572
[TBL] [Abstract][Full Text] [Related]
65. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
[TBL] [Abstract][Full Text] [Related]
66. MiR-16 inhibits hepatocellular carcinoma progression by targeting FEAT through NF-κB signaling pathway.
Su XF; Li N; Meng FL; Chu YL; Li T; Gao XZ
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10274-10282. PubMed ID: 31841182
[TBL] [Abstract][Full Text] [Related]
67. CARMA3/NF-κB signaling contributes to tumorigenesis of hepatocellular carcinoma and is inhibited by sodium aescinate.
Hou H; Li WX; Cui X; Zhou DC; Zhang B; Geng XP
World J Gastroenterol; 2019 Sep; 25(36):5483-5493. PubMed ID: 31576094
[TBL] [Abstract][Full Text] [Related]
68. Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis.
Ma WL; Hsu CL; Yeh CC; Wu MH; Huang CK; Jeng LB; Hung YC; Lin TY; Yeh S; Chang C
Hepatology; 2012 Jul; 56(1):176-85. PubMed ID: 22318717
[TBL] [Abstract][Full Text] [Related]
69. Inhibition of MALAT1 sensitizes liver cancer cells to 5-flurouracil by regulating apoptosis through IKKα/NF-κB pathway.
Ji DG; Guan LY; Luo X; Ma F; Yang B; Liu HY
Biochem Biophys Res Commun; 2018 Jun; 501(1):33-40. PubMed ID: 29702091
[TBL] [Abstract][Full Text] [Related]
70. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway.
Zhao L; Zhang Y
Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008
[TBL] [Abstract][Full Text] [Related]
71. MiR-491 attenuates cancer stem cells-like properties of hepatocellular carcinoma by inhibition of GIT-1/NF-κB-mediated EMT.
Yang X; Ye J; Yan H; Tang Z; Shen J; Zhang J; Yang L
Tumour Biol; 2016 Jan; 37(1):201-9. PubMed ID: 26188902
[TBL] [Abstract][Full Text] [Related]
72. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
73. Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model.
Chen JC; Chuang HY; Hsu FT; Chen YC; Chien YC; Hwang JJ
Oncotarget; 2016 Dec; 7(51):85450-85463. PubMed ID: 27863427
[TBL] [Abstract][Full Text] [Related]
74. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
75. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
[TBL] [Abstract][Full Text] [Related]
76. MicroRNA‑29c‑3p acts as a tumor suppressor gene and inhibits tumor progression in hepatocellular carcinoma by targeting TRIM31.
Lv T; Jiang L; Kong L; Yang J
Oncol Rep; 2020 Mar; 43(3):953-964. PubMed ID: 32020206
[TBL] [Abstract][Full Text] [Related]
77. Knockdown of PHF5A Inhibits Migration and Invasion of HCC Cells via Downregulating NF-
Yang Q; Zhang J; Xu S; Jia C; Meng W; Tang H; Zhang X; Zhang Y; Fu B
Biomed Res Int; 2019; 2019():1621854. PubMed ID: 30766880
[TBL] [Abstract][Full Text] [Related]
78. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
79. RNF31 promotes proliferation and invasion of hepatocellular carcinoma via nuclear factor kappaB activation.
Hoshino K; Nakazawa S; Yokobori T; Hagiwara K; Ishii N; Tsukagoshi M; Igarashi T; Araki K; Harimoto N; Tokunaga F; Shirabe K
Sci Rep; 2024 Jan; 14(1):346. PubMed ID: 38172174
[TBL] [Abstract][Full Text] [Related]
80. Hsa_circ_0026134 expression promoted TRIM25- and IGF2BP3-mediated hepatocellular carcinoma cell proliferation and invasion via sponging miR-127-5p.
Zhang W; Zhu L; Yang G; Zhou B; Wang J; Qu X; Yan Z; Qian S; Liu R
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32648571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
